Table 6

Disease-modifying antirheumatic drug treatments at baseline and after 24 and 60 months

	Women		Men		Difference
	n	%	n	%	p Value
Biological, biological drugs; DMARD, disease-modifying antirheumatic drug; MTX, methotrexate; SAL, sulphasalazine.
DMARDs at baseline					0.93
No DMARD	66	15	41	16
MTX	174	39	92	37
SAL	150	34	86	34
Other DMARD	54	12	31	12
Monotherapy
DMARD Combination	2	0	2	1
Biologicals	0	0	0	0
DMARDs at 24 months					0.74
No DMARD	119	27	77	31
MTX	173	39	94	37
SAL	56	13	35	14
Other DMARD	49	11	21	8
Monotherapy
DMARD Combination	41	9	22	9
Biologicals	6	1	2	1
DMARDs at 60 months					0.34
No DMARD	141	36	69	32
MTX	132	34	77	36
SAL	24	6	20	9
Other DMARD	36	9	22	10
Monotherapy
DMARD Combination	41	10	14	7
Biologicals	19	5	13	6